In October, prices of medicines sold to hospitals in Brazil dropped 0.61%. This is what the Hospital Medicines Price Index (IPM-H) shows, an indicator developed by the Economic Research Institute Foundation (Fipe) in partnership with Bionexo – a leading healthtech in digital solutions for health management.
This is the fourth consecutive drop in drug prices. In July they had fallen -0.74%; in August, 2.05%; in September they fell by 2.48% and in October they fell by 0.61%.
In the year to October, the IPM-H shows a slight increase of 0.11%. In the last 12 months, drug prices have increased by 0.1%.
The monthly variation of the index was also lower than the rise of the IPCA in October, which rose 0.49%, although it surpassed the 0.77% drop in the IGP-M. The IPM-H also closed October below the exchange rate, up 0.25%.
The drop in drug prices last month, according to Fipe and Bionexo, is attributed to the decline in prices of groups with a relevant weight in the IPM-H basket, such as general anti-infectives for use in the nervous, blood and organs systems. hematopoietic.
“The IPM-H fell for the fourth consecutive month, accumulating a decline of 5.8% in this period. As a result, prices have increased by just 0.1% in the last 12 months. This recent movement was influenced by the reduction of taxes on fuels, but the change in the tax should not impact the dynamics of the IPM-H in the coming months”, says Bruno Oliva, economist at Fipe.
Source: CNN Brasil
A journalist with over 7 years of experience in the news industry, currently working at World Stock Market as an author for the Entertainment section and also contributing to the Economics or finance section on a part-time basis. Has a passion for Entertainment and fashion topics, and has put in a lot of research and effort to provide accurate information to readers.
